Zyeocip-SP Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. This multi-ingredient tablet is designed to provide effective relief from pain and inflammation associated with musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, and postoperative conditions. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes, thereby reducing prostaglandin synthesis which mediates inflammation and pain. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation, enhancing tissue healing. The synergistic action of these components results in rapid and sustained analgesic, anti-inflammatory, and antipyretic effects. Zyeocip-SP is indicated for the management of acute and chronic inflammatory conditions where pain relief and reduction of swelling are desired. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairments. The dosage and duration of therapy should be individualized based on clinical response and tolerability.